Literature DB >> 9366736

Acute viral infections of upper respiratory tract in elderly people living in the community: comparative, prospective, population based study of disease burden.

K G Nicholson1, J Kent, V Hammersley, E Cancio.   

Abstract

OBJECTIVE: To evaluate the disease burden of upper respiratory infections in elderly people living at home.
DESIGN: Prospective surveillance of elderly people. INTERVENTION: None.
SETTING: Leicestershire, England
SUBJECTS: 533 subjects 60 to 90 years of age. MAIN OUTCOME MEASURES: Pathogens, symptoms, restriction of activity, duration of illness, medical consultations, interval between onset of illness and medical consultation, antibiotic use, admission to hospital, and death.
RESULTS: 231 pathogens were identified for 211 (43%) of 497 episodes for which diagnostic specimens were available: 121 (52%) were rhinoviruses, 59 (26%) were coronaviruses, 22 (9.5%) were influenza A or B, 17 (7%) were respiratory syncytial virus, 7 (3%) were parainfluenza viruses, and 3 (1%) were Chlamydia species; an adenovirus and Mycoplasma pneumoniae caused one infection each. Infections occurred at a rate of 1.2 episodes per person per annum (95% confidence interval 1.0 to 1.7; range 0-10) and were clinically indistinguishable. Lower respiratory tract symptoms complicated 65% of upper respiratory infections and increased the medical consultation rate 2.4-fold (chi 2 test P < 0.001). The median interval between onset of illness and medical consultation was 3 days for influenza and 5 days for other infections. Rhinoviruses caused the greatest disease burden overall followed by episodes of unknown aetiology, coronaviruses, influenza A and B, and respiratory syncytial virus.
CONCLUSIONS: Respiratory viruses cause substantial morbidity in elderly people. Although respiratory syncytial virus and influenza cause considerable individual morbidity, the burden of disease from rhinovirus infections and infections of unknown aetiology seems greater overall. The interval between onset of illness and consultation together with diagnostic difficulties raises concern regarding the role of antiviral drugs in treating influenza.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9366736      PMCID: PMC2127683          DOI: 10.1136/bmj.315.7115.1060

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


  138 in total

1.  The duration and magnitude of influenza epidemics: a study of surveillance data from sentinel general practices in England, Wales and the Netherlands.

Authors:  D M Fleming; M Zambon; A I Bartelds; J C de Jong
Journal:  Eur J Epidemiol       Date:  1999-05       Impact factor: 8.082

2.  Do hospital physicians have a role in reducing antibiotic prescribing in the community?

Authors:  J Macfarlane; W F Holmes; R Macfarlane
Journal:  Thorax       Date:  2000-02       Impact factor: 9.139

3.  Mass influenza vaccination in Ontario: is it worthwhile?

Authors:  V Demicheli
Journal:  CMAJ       Date:  2001-01-09       Impact factor: 8.262

4.  Economic evaluations of influenza vaccination in healthy working-age adults. Employer and society perspective.

Authors:  S C Wood; V H Nguyen; C Schmidt
Journal:  Pharmacoeconomics       Date:  2000-08       Impact factor: 4.981

5.  Improved detection of rhinoviruses by nucleic acid sequence-based amplification after nucleotide sequence determination of the 5' noncoding regions of additional rhinovirus strains.

Authors:  K Loens; M Ieven; D Ursi; C De Laat; P Sillekens; P Oudshoorn; H Goossens
Journal:  J Clin Microbiol       Date:  2003-05       Impact factor: 5.948

Review 6.  Immunity to influenza: the challenges of protecting an aging population.

Authors:  Jacqueline M Katz; Julie Plowden; Mary Renshaw-Hoelscher; Xiuhua Lu; Terrence M Tumpey; Suryaprakash Sambhara
Journal:  Immunol Res       Date:  2004       Impact factor: 2.829

7.  How to deal with influenza?

Authors:  Tom Jefferson
Journal:  BMJ       Date:  2004-09-18

8.  Antibiotic treatment for influenza does not affect resolution of illness, secondary visits or lost workdays.

Authors:  Fabrice Carrat; Michael Schwarzinger; Bruno Housset; Alain-Jacques Valleron
Journal:  Eur J Epidemiol       Date:  2004       Impact factor: 8.082

9.  Common cold.

Authors:  Graham Worrall
Journal:  Can Fam Physician       Date:  2011-11       Impact factor: 3.275

Review 10.  Vaccines for the common cold.

Authors:  Daniel Simancas-Racines; Juan Va Franco; Claudia V Guerra; Maria L Felix; Ricardo Hidalgo; Maria José Martinez-Zapata
Journal:  Cochrane Database Syst Rev       Date:  2017-05-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.